ZA858867B - Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same - Google Patents
Tricyclo compounds,a process for their production and a pharmaceutical composition containing the sameInfo
- Publication number
- ZA858867B ZA858867B ZA858867A ZA858867A ZA858867B ZA 858867 B ZA858867 B ZA 858867B ZA 858867 A ZA858867 A ZA 858867A ZA 858867 A ZA858867 A ZA 858867A ZA 858867 B ZA858867 B ZA 858867B
- Authority
- ZA
- South Africa
- Prior art keywords
- production
- pharmaceutical composition
- same
- composition containing
- tricyclo compounds
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848430455A GB8430455D0 (en) | 1984-12-03 | 1984-12-03 | Fr-900506 substance |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA858867B true ZA858867B (en) | 1986-09-24 |
Family
ID=10570610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA858867A ZA858867B (en) | 1984-12-03 | 1985-11-19 | Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPS61148181A (en) |
GB (1) | GB8430455D0 (en) |
ZA (1) | ZA858867B (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
JP2822389B2 (en) * | 1987-06-05 | 1998-11-11 | 藤沢薬品工業株式会社 | Anti-FR-900506 substance antibody and highly sensitive enzyme immunoassay |
EP0323865A1 (en) * | 1988-01-07 | 1989-07-12 | Merck & Co. Inc. | Novel immunosuppressant agent |
BR8907766A (en) * | 1988-11-21 | 1991-08-27 | Du Pont | PROCESS FOR THE INTERCONVERSION OF TWO DISTINCT CRYSTALLINE FORMS OF A HERBICIDE SULPHONAMIDE PYRIDINE |
IE66485B1 (en) * | 1989-07-05 | 1996-01-10 | Fujisawa Pharmaceutical Co | Aqueous liquid composition for external use |
IE904050A1 (en) * | 1989-11-13 | 1991-05-22 | Merck & Co Inc | Aminomacrolides and derivatives having immunosuppressive¹activity |
KR0177158B1 (en) * | 1990-03-01 | 1999-03-20 | 후지사와 도모기찌로 | Solutions for inhibition of immune functions containing tricyclic compounds |
US5260301A (en) * | 1990-03-01 | 1993-11-09 | Fujisawa Pharmaceutical Co., Ltd. | Pharmaceutical solution containing FK-506 |
CA2054983A1 (en) * | 1990-11-08 | 1992-05-09 | Sotoo Asakura | Suspendible composition and process for preparing the same |
US5250678A (en) * | 1991-05-13 | 1993-10-05 | Merck & Co., Inc. | O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity |
DE69230541T2 (en) * | 1991-10-31 | 2000-08-24 | Fujisawa Pharmaceutical Co., Ltd. | Liposome preparation containing a tricyclic compound |
AU675651B2 (en) * | 1992-06-23 | 1997-02-13 | Zaidan Hojin Biseibutsu Kagaku Kenkyukai | Novel antibiotics with immunosuppressive activity, delaminomycins, and production thereof |
WO1994000438A1 (en) * | 1992-06-24 | 1994-01-06 | Yamanouchi Pharmaceutical Co., Ltd. | Novel benzodiazepine derivative |
US5601844A (en) * | 1992-11-18 | 1997-02-11 | Fujisawa Pharmaceutical Co., Ltd. | Sustained release medicinal preparation |
JPH06345646A (en) * | 1993-06-08 | 1994-12-20 | Fujisawa Pharmaceut Co Ltd | Lotion preparation |
CN1259053A (en) * | 1997-04-11 | 2000-07-05 | 藤泽药品工业株式会社 | Medicinal composition |
GB0012383D0 (en) * | 2000-05-22 | 2000-07-12 | Novartis Ag | Organic compounds |
ITMI20042098A1 (en) * | 2004-11-03 | 2005-02-03 | Antibioticos Spa | PROCESS FOR TACROLIMUS PURIFICATION |
TW200635934A (en) * | 2005-01-05 | 2006-10-16 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Amorphous tacrolimus and preparation thereof |
ITMI20051549A1 (en) * | 2005-08-05 | 2007-02-06 | Antibioticos Spa | PURIFICATION OF TACROLIMUS ON VEGETABLE DIMORIGINE SUPPORTS |
JP4992716B2 (en) | 2005-08-12 | 2012-08-08 | アステラス製薬株式会社 | Method for identifying target protein of drug and method for screening therapeutic agent for diabetes using target protein |
CA2660804A1 (en) | 2006-08-31 | 2008-03-06 | Astellas Pharma Inc. | Reverse targeting lipid vesicle |
TW200932240A (en) | 2007-10-25 | 2009-08-01 | Astellas Pharma Inc | Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production |
ES2478845T3 (en) | 2008-10-08 | 2014-07-23 | Takata Seiyaku Co., Ltd. | Preparation of tacrolimus for external applications |
JP6210983B2 (en) | 2012-07-06 | 2017-10-11 | 合同酒精株式会社 | Method for separating cyclic macrolide compounds |
-
1984
- 1984-12-03 GB GB848430455A patent/GB8430455D0/en active Pending
-
1985
- 1985-11-19 ZA ZA858867A patent/ZA858867B/en unknown
- 1985-12-03 JP JP27204285A patent/JPS61148181A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
GB8430455D0 (en) | 1985-01-09 |
JPH0338276B2 (en) | 1991-06-10 |
JPS61148181A (en) | 1986-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA858867B (en) | Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same | |
GB9019174D0 (en) | Tetrahydropyrane compounds,a process for their production and a pharmaceutical composition containing the same | |
IL67085A (en) | Tetrapeptides,a process for manufacturing them and pharmaceutical compositions containing them | |
IL64345A (en) | Substituted phenoxypropanolamine derivatives,process for the production thereof and pharmaceutical compositions containing the same | |
GB9015098D0 (en) | Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same | |
DE3373100D1 (en) | 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition | |
EP0254583A3 (en) | Parasiticidal milbemicyn derivatives, a process for their production, and compositions containing the same | |
GB9014136D0 (en) | Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same | |
DE3172006D1 (en) | Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof | |
PH24599A (en) | Amonoycyllabdanes, pharmaceutical compositions and a process for the preparations thereof | |
PH21118A (en) | Heterocyclic derivatives, a process for their preparation the pharmaceutical composition containing them | |
EP0110397A3 (en) | Polyprenyl compound, process for the production thereof and drug containing the same | |
HUT41984A (en) | Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides | |
AU584097B2 (en) | New tetracyclo compounds, a process for their production and a pharmaceutical composition containing the same | |
DE3368637D1 (en) | Tricyclic compounds, a process for their production and pharmaceutical compositions containing said compounds | |
GB2154899B (en) | Stiffening materials, a process for their production and the use thereof | |
GB9012963D0 (en) | Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same | |
JPS6468379A (en) | Novel compound, its production and pharmaceutical composition containing the same | |
DE3568041D1 (en) | Sulfonamidines, a process for preparing them and pharmaceutical compositions containing them | |
DE3471931D1 (en) | Novel quinazolinone derivative, a process for preparing the same and a pharmaceutical composition | |
GB9014881D0 (en) | Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same | |
DE3571978D1 (en) | Imidazolylalkoxyindanic derivatives, a process for preparing them and pharmaceutical composition containing them | |
DE3472553D1 (en) | Antihyperlipidemic n-benzoylsulfamates, n-benzylsulfamates and benzylsulfonamides, a therapeutic composition containing same and a process for the production thereof | |
ZA856775B (en) | Histargin-related compounds,a process for their preparation and their use as medicaments | |
GB9016115D0 (en) | Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same |